Report overview
The kit is based on real-time RT-PCR technology, for the qualitative detection of SARS-CoV-2 specific RNA. The assay includes a positive control and an internal control.
This report contains market size and forecasts of Novel Coronavirus Nucleic Acid Detection Kit in global, including the following market information:
Global Novel Coronavirus Nucleic Acid Detection Kit Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Novel Coronavirus Nucleic Acid Detection Kit Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Novel Coronavirus Nucleic Acid Detection Kit companies in 2022 (%)
The global Novel Coronavirus Nucleic Acid Detection Kit market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Pharyngeal Swab Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Novel Coronavirus Nucleic Acid Detection Kit include Abbott, ID SOLUTIONS, altona Diagnostics, GeneProof, Roche Diagnostics, Aurora, 3B BlackBio Biotech India Limited, CerTest Biotec, SL and Hologic, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Novel Coronavirus Nucleic Acid Detection Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Coronavirus Nucleic Acid Detection Kit Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Novel Coronavirus Nucleic Acid Detection Kit Market Segment Percentages, by Type, 2022 (%)
Pharyngeal Swab
Nasal Swab
Other
Global Novel Coronavirus Nucleic Acid Detection Kit Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Novel Coronavirus Nucleic Acid Detection Kit Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Novel Coronavirus Nucleic Acid Detection Kit Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Novel Coronavirus Nucleic Acid Detection Kit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Coronavirus Nucleic Acid Detection Kit revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Novel Coronavirus Nucleic Acid Detection Kit revenues share in global market, 2022 (%)
Key companies Novel Coronavirus Nucleic Acid Detection Kit sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Novel Coronavirus Nucleic Acid Detection Kit sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
ID SOLUTIONS
altona Diagnostics
GeneProof
Roche Diagnostics
Aurora
3B BlackBio Biotech India Limited
CerTest Biotec, SL
Hologic
Biogerm Medical
GeneoDx Biotech
Liferiver
Mole Bioscience
Bioperfectus
Rendu Biotechnology
Applied Biological
Sansure Biotech
Guangodng Hecin Scientific, Inc.
TransGen Biotech
Coyote Bioscience
Daan Gene
Orient Gene
Nanjing Synthgene Medical Technology
Shenzhen Uni-medica Technology
Hybribio
BGI Group
